Express News | Scisparc Ltd - Pursuant to Amendment, Company Made Available to Automax an Additional Loan in Amount of $1.0 Mln Under Terms Similar to Loan Agreement
Express News | Scisparc Ltd - Entered Into an Amendment to Bridge Loan Agreement With Automax Motors Ltd.
Express News | Scisparc Ltd - All Outstanding Shares of Automax Will Be Converted Into Right to Receive Ordinary Shares of Scisparc
Express News | Scisparc Ltd - Following Acquisition Scisparc Shareholders Will Hold Together About 50.01% of Share Capital of Post-Closing Combined Company
Express News | Scisparc Ltd - Will Acquire 100% of Automax and Establish a New Wholly-Owned Israeli Subsidiary
Clearmind Medicine Submits Three International Patent Applications for Next Generation Classic Psychedelic-Based Compounds Under Its SciSparc Ltd Collaboration
Clearmind Medicine Inc. ((Nasdaq, CSE:CMND), (FSE: CWY) ("Clearmind" or the "company"), a biotech company focused on discovery and development of novel psychedelic-derived therapeutics to solve major
SciSparc Ltd. Announces $20 Million Standby Equity Purchase Agreement
TEL AVIV, Israel, Jan. 24, 2024 (GLOBE NEWSWIRE) -- SciSparc Ltd. (NASDAQ:SPRC) ("Company" or "SciSparc"), a specialty clinical-stage pharmaceutical company focusing on the development of therapies to treat disorders
Why SciSparc Ltd Stock Is Blasting Higher
SciSparc Ltd. (NASDAQ:SPRC) shares are trading higher Friday after the company announced it has launched a clinical trial of its combination of cannabidiol (CBD) and SciSparc's proprietary Palmitoylet
Why SciSparc Ltd Stock Is Lighting Up
SciSparc Ltd (NASDAQ:SPRC) shares are trading higher Wednesday after the company announced positive results from the Phase IIa clinical trial of its investigational compound for the treatment of agita
What's Going On With SciSparc Ltd Stock?
SciSparc Ltd. (NASDAQ:SPRC) shares are blasting higher Tuesday. The company recently announced the closing of a $5 million private placement and regained compliance with the Nasdaq minimum bid price r
Aegis Capital Corp. Acted as Exclusive Placement Agent on a $5.0 Million Private Placement for SciSparc Ltd. (NASDAQ: SPRC)
NEW YORK, NY / ACCESSWIRE / October 16, 2023 / Aegis Capital Corp. acted as Exclusive Placement Agent on a $5.0 Million Private Placement for SciSparc Ltd. (NASDAQ:SPRC).About SciSparc Ltd.SciSparc Lt
SciSparc Ltd. Regains Compliance With Nasdaq Minimum Bid Price Notification
Tel Aviv, Oct. 16, 2023 (GLOBE NEWSWIRE) -- SciSparc Ltd. (Nasdaq: SPRC), a specialty, clinical-stage pharmaceutical company focusing on the development of therapies to treat disorders of the centr
SciSparc Ltd. Announces Closing of $5.026 Million Private Placement
TEL AVIV, ISRAEL, Oct. 13, 2023 (GLOBE NEWSWIRE) -- SciSparc Ltd. (Nasdaq: SPRC) ("SciSparc" or the "Company"), today announced the closing of its previously announced private placement with an inst
SciSparc Ltd. Announces Pricing of $5.026 Million Private Placement
TEL AVIV, ISRAEL, Oct. 11, 2023 (GLOBE NEWSWIRE) -- SciSparc Ltd. (NASDAQ:SPRC) ("SciSparc" or the "Company"), today announced that it has entered into a securities purchase agreement with an institutional investor to
Aegis Capital Corp. Acted as Sole Bookrunner on a $1.3 Million Underwritten Public Offering for SciSparc Ltd. (NASDAQ: SPRC)
NEW YORK, NY / ACCESSWIRE / August 15, 2023 / Aegis Capital Corp. acted as Sole Bookrunner on a $1.3 Million Underwritten Public Offering for SciSparc Ltd. .About SciSparc Ltd.SciSparc Ltd. is a specialty
SciSparc Ltd. Closes $1.3 Million Underwritten Public Offering
TEL AVIV, Israel, Aug. 14, 2023 (GLOBE NEWSWIRE) -- SciSparc Ltd. (NASDAQ:SPRC) ("SciSparc" or the "Company") today announced the closing of a firm commitment underwritten public offering with gross proceeds to the
SciSparc Ltd. Announces Pricing of $1.3 Million Underwritten Public Offering
TEL AVIV, ISRAEL, Aug. 10, 2023 (GLOBE NEWSWIRE) -- SciSparc Ltd. (Nasdaq: SPRC) ("SciSparc" or the "Company") today announced the pricing of a firm commitment underwritten public offering with gro
Express News | SciSparc Ltd.: Announces Proposed Underwritten Public Offering of Approximately $1.3M
SciSparc Ltd. Announces Proposed Underwritten Public Offering of Approximately $1.3 Million
TEL AVIV, Israel, Aug. 09, 2023 (GLOBE NEWSWIRE) -- SciSparc Ltd. (NASDAQ:SPRC) ("SciSparc" or the "Company") today announced that it intends to offer its securities in a firm commitment underwritten public offering.
SciSparc Ltd. (NASDAQ:SPRC) Sees Significant Increase in Short Interest
SciSparc Ltd. (NASDAQ:SPRC – Get Rating) was the target of a large increase in short interest during the month of February. As of February 28th, there was short interest totalling 133,900 shares, an
No Data